Literature DB >> 15952301

Fatal adenovirus infection indistinguishable from thrombotic microangiopathy after allogeneic CD34+ peripheral progenitor cell transplantation.

Hiromasa Yabe1, Kinya Hattori, Hiroyasu Inoue, Masae Matsumoto, Satoshi Hamanoue, Aiko Hiroi, Takashi Koike, Shunichi Kato, Kazuo Shimamura, Miharu Yabe.   

Abstract

A 10-year-old boy with acute lymphoblastic leukemia in second relapse received CD34+ purified allogeneic peripheral blood stem cell transplantation (PBSCT) from his HLA-haploidentical father. The patient developed grade II acute GVHD and received high-dose methyl-prednisolone starting on day + 13 posttransplant. Renal dysfunction followed by massive gastrointestinal bleeding was observed from day + 14. The laboratory findings including elevated serum LDH, increased RBC fragmentation, higher level of thrombomodulin and undetectable haptoglobin corresponded with the diagnosis of thrombotic microangiopathy (TMA). In spite of various treatments, the patient died of multiple organ failure on day + 93. Post-mortem examination revealed systemic adenovirus infection without histological findings of TMA. Severe adenovirus infection may be confused with TMA, and should be distinguished by rapid virological assay.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15952301

Source DB:  PubMed          Journal:  Tokai J Exp Clin Med        ISSN: 0385-0005


  4 in total

1.  Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy.

Authors:  Jeremy D Rubinstein; Xiang Zhu; Carolyn Lutzko; Tom Leemhuis; Jose A Cancelas; Sonata Jodele; Catherine M Bollard; Patrick J Hanley; Stella M Davies; Michael S Grimley; Adam S Nelson
Journal:  Blood Adv       Date:  2020-07-28

2.  Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis.

Authors:  Siribha Changsirikulchai; David Myerson; Katherine A Guthrie; George B McDonald; Charles E Alpers; Sangeeta R Hingorani
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-14       Impact factor: 8.237

Review 3.  Progress in Treatment of Viral Infections in Children with Acute Lymphoblastic Leukemia.

Authors:  Maria Moschovi; Maria Adamaki; Spiros A Vlahopoulos
Journal:  Oncol Rev       Date:  2016-06-30

Review 4.  Tackling COVID-19 infection through complement-targeted immunotherapy.

Authors:  Sonata Jodele; Jörg Köhl
Journal:  Br J Pharmacol       Date:  2020-07-27       Impact factor: 9.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.